NCT01512251
- Conditions
- BRAF Mutant Metastatic Melanoma, Melanoma, Neoplasms, +10 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
Clinical trial condition
Explore clinical trials studying BRAF Mutant Metastatic Melanoma. Study availability and eligibility vary by location and protocol.
NCT01512251